San Carlos, CA, United States of America

Josephine M Cardarelli

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 4.9

ph-index = 12

Forward Citations = 1,814(Granted Patents)


Location History:

  • Redwood City, CA (US) (2019)
  • San Carlos, CA (US) (2009 - 2022)
  • Wellesley, MA (US) (2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):

Title: Josephine M. Cardarelli: A Pioneer in Monoclonal Antibody Research

Introduction

Josephine M. Cardarelli, based in San Carlos, California, is a notable inventor with an impressive portfolio of 43 patents. Her groundbreaking work primarily revolves around human monoclonal antibodies, which have significant implications in treating various cancers and inflammatory disorders.

Latest Patents

Among her latest patents, Cardarelli has been recognized for her remarkable innovation in the field of immunology with her patent on human monoclonal antibodies that bind CXCR4 and their uses. This patent outlines isolated monoclonal antibodies that exhibit high affinity toward the CXCR4 receptor. Additionally, the disclosure includes nucleic acid molecules encoding these antibodies, expression vectors, and host cells, along with methods for effective antibody expression. The patents also introduce immunoconjugates, bispecific molecules, and pharmaceutical compositions including her antibodies. Furthermore, methods for detecting CXCR4 and treating conditions such as various cancers, inflammatory disorders, and HIV infections using anti-CXCR4 antibodies are emphasized in her work.

Another significant patent addresses the treatment of Waldenstrom's macroglobulinemia, providing a method for treating patients afflicted with this condition by administering an antibody that specifically binds to the CXCR4 receptor on WM cells. This innovative approach showcases her dedication to advancing therapeutic strategies in oncology.

Career Highlights

Cardarelli has made significant contributions during her tenure at renowned companies like Medarex Inc. and E.R. Squibb & Sons, LLC. Her work in these organizations has not only enriched her professional journey but has also led to the development of critical therapeutic interventions.

Collaborations

Throughout her career, Cardarelli has collaborated with esteemed colleagues, including Mohan Srinivasan and Alison Witte. These partnerships have enabled the exchange of ideas and fostered innovation, further enhancing the landscape of monoclonal antibody research.

Conclusion

Josephine M. Cardarelli's contributions to the field of monoclonal antibodies underscore her status as a distinguished inventor. With her 43 patents, she is paving the way for novel therapeutic solutions that hold the potential to change lives and improve treatment outcomes for patients facing challenging health conditions. Her commitment to innovation and collaboration continues to inspire the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…